120 related articles for article (PubMed ID: 6457635)
1. Neocarzinostatin chromophore: purification of the major active form and characterization of its spectral and biological properties.
Napier MA; Holmquist B; Strydom DJ; Goldberg IH
Biochemistry; 1981 Sep; 20(19):5602-8. PubMed ID: 6457635
[No Abstract] [Full Text] [Related]
2. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
[TBL] [Abstract][Full Text] [Related]
3. Effect of nonprotein chromophore removal on neocarzinostatin action.
Napier MA; Kappen LS; Goldberg IH
Biochemistry; 1980 Apr; 19(9):1767-73. PubMed ID: 6445749
[No Abstract] [Full Text] [Related]
4. Neocarzinostatin: spectral characterization and separation of a non-protein chromophore.
Napier MA; Holmquist B; Strydom DJ; Goldberg IH
Biochem Biophys Res Commun; 1979 Jul; 89(2):635-42. PubMed ID: 39562
[No Abstract] [Full Text] [Related]
5. Isolation and fast purification of neocarzinostatin by FPLC-ion exchange chromatography.
Denklau D; Köhnlein W; Lüders G; Stellmach J
Z Naturforsch C Biosci; 1983; 38(11-12):939-42. PubMed ID: 6230805
[TBL] [Abstract][Full Text] [Related]
6. The biologically active site of neocarzinostatin-chromophore.
Koide Y; Ito A; Edo K; Ishida N
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4425-8. PubMed ID: 2951017
[No Abstract] [Full Text] [Related]
7. Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore.
Urbaniak MD; Frost LM; Bingham JP; Kelland LR; Hartley JA; Woolfson DN; Caddick S
Bioorg Med Chem Lett; 2003 Jun; 13(12):2025-7. PubMed ID: 12781188
[TBL] [Abstract][Full Text] [Related]
8. Specific G2 block in HeLa-S3 cells by neocarzinostatin.
Ebina T; Otsuki K; Seto M; Ishida N
Eur J Cancer (1965); 1975 Mar; 11(3):155-8. PubMed ID: 124253
[No Abstract] [Full Text] [Related]
9. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
Napier MA; Goldberg IH
Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
[TBL] [Abstract][Full Text] [Related]
10. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
Stassinopoulos A; Goldberg IH
Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory mechanism of in vitro protein phosphorylation by a nonprotein chromophore removed from neocarzinostatin.
Ohtsuki K; Sato T; Koike T; Koyama K; Ishida N
Biochim Biophys Acta; 1981 Mar; 673(2):147-56. PubMed ID: 6260230
[TBL] [Abstract][Full Text] [Related]
12. Roles of chromophore and apo-protein in neocarzinostatin action.
Kappen LS; Napier MA; Goldberg IH
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
[TBL] [Abstract][Full Text] [Related]
13. Light-induced DNA cleavage by esperamicin and neocarzinostatin.
Uesawa Y; Kuwahara J; Sugiura Y
Biochem Biophys Res Commun; 1989 Oct; 164(2):903-11. PubMed ID: 2554905
[TBL] [Abstract][Full Text] [Related]
14. A facile method of purification of neocarzinostatin, an antitumor protein.
Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen bromide adduct of neocarzinostatin chromophore: one of the stable derivatives of native neocarzinostatin chromophore.
Edo K; Akiyama-Murai Y; Saito K; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Sep; 41(9):1272-4. PubMed ID: 2972669
[No Abstract] [Full Text] [Related]
16. Absolute configuration of the amino sugar moiety of the neocarzinostatin chromophore.
Edo K; Akiyama Y; Saito K; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1986 Nov; 39(11):1615-9. PubMed ID: 2947887
[No Abstract] [Full Text] [Related]
17. Degradation of HeLa cell chromatin by neocarzinostatin and its chromophore.
McHugh MM; Woynarowski J; Beerman T
Biochim Biophys Acta; 1982 Jan; 696(1):7-14. PubMed ID: 6211192
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of non-protein chromophore and its degradation product from antibiotic C-1027.
Otani T; Minami Y; Sakawa K; Yoshida K
J Antibiot (Tokyo); 1991 May; 44(5):564-8. PubMed ID: 2061198
[No Abstract] [Full Text] [Related]
19. Biological activities and physicochemical properties of pre-neocarzinostatin and UV-irradiated neocarzinostatin.
Iseki S; Koide Y; Ebina T; Ishida N
J Antibiot (Tokyo); 1980 Jan; 33(1):110-3. PubMed ID: 6445350
[No Abstract] [Full Text] [Related]
20. Unstability of neocarzinostatin-chromophore.
Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
